| Literature DB >> 25286911 |
Lavannya Sabharwal1, Daisuke Kamimura1, Jie Meng1, Hidenori Bando1, Hideki Ogura1, Chiemi Nakayama1, Jing-Jing Jiang1, Noriko Kumai1, Hironao Suzuki1, Toru Atsumi1, Yasunobu Arima1, Masaaki Murakami2.
Abstract
The brain-blood barrier (BBB) tightly limits immune cell migration into the central nervous system (CNS), avoiding unwanted inflammation under the normal state. However, immune cells can traverse the BBB when inflammation occurs within the CNS, suggesting a certain signal that creates a gateway that bypasses the BBB might exist. We revealed the inflammation amplifier as a mechanism of this signal, and identified dorsal vessels of the fifth lumber (L5) spinal cord as the gateway. The inflammation amplifier is driven by a simultaneous activation of NF-κB and STATs in non-immune cells, causing the production of a large amount of inflammatory chemokines to open the gateway at L5 vessels. It was found that the activation of the amplifier can be modulated by neural activation and artificially operated by electric pulses followed by establishment of new gateways, Gateway Reflex, at least in mice. Furthermore, genes required for the inflammation amplifier have been identified and are highly associated with various inflammatory diseases and disorders in the CNS. Thus, physical and/or pharmacological manipulation of the inflammation amplifier holds therapeutic value to control neuro-inflammation.Entities:
Keywords: Gateway reflex; NF-κB; STAT; blood–brain barrier; inflammation amplifier
Mesh:
Substances:
Year: 2014 PMID: 25286911 DOI: 10.1093/jb/mvu057
Source DB: PubMed Journal: J Biochem ISSN: 0021-924X Impact factor: 3.387